Caricamento...
Will targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies?
The constitutive activation of phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway has been demonstrated to be critical in clinical cancer patients as well as in laboratory cancer models including hematological malignancies. Great efforts ha...
Salvato in:
| Pubblicato in: | Stem Cell Investig |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4981705/ https://ncbi.nlm.nih.gov/pubmed/27583254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2016.07.02 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|